Eretinib-(Qinlock)- (May 2020)- Gastro-Intestinal Tumors

Drug Name:
Eretinib-(Qinlock)- (May 2020)- Gastro-Intestinal Tumors

List Of Brands:

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation

   

Drug Interaction:

DRUG INTERACTIONS- summary

 Strong CYP3A Inhibitors:                                                                                                   Monitor more frequently for adverse reactions. 

Strong CYP3A Inducers:                                                                                                          Avoid concomitant use of strong CYP3A inducers.